Introduction
It is now well recognized that the synthesis and secretion of procoagulant activity (PCA)' by monocyte/macrophages (Mo/ Ma) is an integral component of the host's immune response (1, 2) . These cells can be stimulated by a number of immunostimulatory molecules in collaboration with T lymphocytes to produce direct activators of the coagulation system (3) . The induction of this Mo/Ma PCA is tightly controlled by both helper and suppressor cells as well as soluble mediators (4) . Furthermore, Geczy et al. have shown that Mo/Ma production of PCA is a measure of antigen specific stimulation (5) .
Studies by Schreiner et al. have suggested that proliferating cells in glomerulonephritis (GN) are derived from circulating monocytes as well as intrinsic glomerular cells (6) . Holdsworth and colleagues, in experimental nephritis in the rabbit, have shown that macrophages are present during the development of 1 . Abbreviations used in this paper: BG, beta glucuronidase; BUN, blood urea nitrogen; Con A, concanavalin A; GN, glomerulonephritis; IC, immune complex; IL-I and IL-2, interleukin I and 2; LPS, lipopolysaccharide; Mo/Ma, monocyte/macrophage; PA, plasminogen activator, PCA, procoagulant activity; PMSF, phenylmethylsulfonyl fluoride; TBS, Tris-buffered saline. injury, and depletion with a specific anti-macrophage serum was able to abrogate glomerular injury (7) . Other studies have pointed out the importance of the coagulation system in GN in both experimental models and human disease (8, 9) .
We have shown that elevation of monocyte PCA correlates with the presence of proliferative GN in patients with systemic lupus erythematosus (10) . More recently, Wiggins and colleagues demonstrated an elevation in PCA in isolated glomeruli during the development of nephrotoxic nephritis at a time when disease and renal dysfunction were developing (1 1). Thus, there is good evidence that monocyte PCA is intimately involved in mediation of injury in both human and experimental GN; however, the mechanisms responsible for the induction of PCA in vivo are not well understood.
The BXSB male mouse develops a lupuslike syndrome consisting of a fatal immune complex (IC) GN, thymic atrophy, and lymphoid hyperplasia. 50% mortality occurs at 5 mo (12) . Some investigators have reported increases in numbers of Mo/ Ma with disease progression in these mice; however, no studies of macrophage function have been reported (13) .
The purpose ofthese studies was to determine whether PCA might also play a role in murine lupus nephritis and if so to examine the mechanisms responsible for its induction.
Methods
Mice BXSB male mice, 4 wk ofage, were obtained from Jackson Laboratories, Bar Harbour, ME, and were housed in the Department of Laboratory and Animal Services at the University of Toronto, Blood urea nitrogen (BUN) was determined using Azostix (Miles Laboratories, Rexdale, Ontario, Canada). 
PCA
Samples ofviable cells or frozen-thawed and sonicated cells were assayed for the capacity to shorten the spontaneous recalcification time of human plasma in a one-stage clotting assay, as described previously (1) . Purified splenic mononuclear cells, macrophages, or lymphocytes at 1 X 106/ml in 12 X 75-mm polypropylene tubes (Falcon Plastics, Div. Becton-Dickinson & Co., Oxnard, CA) were subjected to three cycles of freeze-thaw and sonication (total content PCA). To 0.1 ml ofthe cellular homogenate or viable cells at 370C was added 0.1 ml of citrated normal human platelet-poor plasma or factor-deficient plasma (Helena Laboratories, Beaumont, TX), and 0.1 ml of 25 mM CaCl2 was added to start the reaction. The time in seconds for the appearance of a fibrin gel was recorded. To establish units, a rabbit brain thromboplastin standard at 36 mg dry mass per milliliter (Dade Div., American Hospital Supply, Miami, FL) was assigned a value of 100,000 mU. Log dilutions of this standard were used to derive a standard curve as previously described (1) . Similarly, log dilutions of Mo/Ma expressing PCA gave a linear curve parallel to the thromboplastin standard when plotted on a log-log scale. Media with or without 10% fetal calf serum and buffers were all without activity.
Endotoxin contamination
All media, buffers, supernatants, and plasmas (delipidated with chloroform) (15) were assayed for endotoxin contamination by a standard limulus assay (E. Toxate; Sigma Chemical Co.) and contained <0.1 ng/ml of endotoxin, the lower limits of the assay.
Renal pathology
Whole kidneys were removed from all animals and specimens for histologic study were embedded in paraffin. Sections were stained with hematoxylin and eosin and were reviewed by a pathologist (Dr. Sweet) in a double-blind fashion. Pathologic diagnosis was made according to World Health Organization criteria (16) .
Interleukin I (IL-1) production Supernatants capable ofinducing PCA were assessed for the presence of IL-1 activity by the technique described by Mizel et al. (17) . IL-2 production IL-2 activity was assayed as described by Gillis et al. (18) . CTLL IL-2-dependent cells, provided by Dr. Gordon Mills (Hospital for Sick Children, Toronto, Canada), were grown in IL-2-containing supernatants, washed, and adjusted to 2 X 105/ml of complete medium, and 0.1 ml of the cell suspension was distributed into each well of flat-bottom microtiter plates. Each well also received 0.1 ml of a log2 serial dilution of the supernatant to be titrated and cultures were incubated for 48 h. Tritiated thymidine (I MCi) was added, and 8 h later the cultures were harvested and [3H]thymidine incorporation measured. Each sample was tested in triplicate. I U of IL-2 activity was defined as the amount ofIL-2-containing supernatant that produced 50% ofthe maximal proliferative response obtained with the reference IL-2 sample. A reference IL-2 sample was obtained by stimulating normal rat spleen cells with Con A and was used as a positive control as well as for routine maintenance ofthe CTLL cells.
Plasminogen activator (PA)
Plasminogen was isolated from citrated normal human fresh frozen plasma according to a modification ofthe method ofDeutsch and Mertz (19) . 70 IU ancrod (Connaught Laboratories) was added to each liter of plasma and the plasma was stirred gently overnight at 40C. After filtration, the plasma was diluted 1:1 with 0.1 M phosphate buffer, pH 7.4, containing 3 mM EDTA and 2 mM phenylmethylsulfonyl fluoride (PMSF) and was loaded onto a 2.0 X 30-cm Sepharose-lysine column (Pharmacia Chemicals, Montreal, Quebec, Canada). The column was washed with 0.1 M phosphate buffer, pH 7.4, at 220C until the absorbance at 280 nM was <0.01 and the plasminogen was eluted from the column with 0.2 M epsilon amino caproic acid in 0.3 M phsophate, pH 7.4, containing 3 mM EDTA and 2 mM PMSF at 40C. The plasminogen was dialyzed overnight in 5 mM phosphate buffer, pH 7.4, and passed through a 2.0 X 30-cm Sephadex G25 medium column at 40C (Pharmacia Chemicals). The protein peak was recovered and dialyzed against 0.1 M Tris-buffered saline (TBS), pH 6.4, at 40C. Protein concentration was determined in a standard Lowry assay and plasminogen was stored in aliquots at -70'C. Purity of plasminogen was determined by polyacrylamide gel electrophoresis in which a 90,000-mol-wt doublet was seen when the gel was loaded with 40 ug protein.
Purified fibrinogen (Kabi; Kabivitrum, Stockholm, Sweden) was radioiodinated enzymatically with immobilized lactoperoxidase (Biorad Radiochemicals Inc., Mississauga, Ontario, Canada) according to the method ofYork and Blomback (20) . Radiolabeled 
Results

PCA in BXSB male mice
The BXSB mice used in this study showed a disease pattern similar to that previously reported with 50% mortality occurring at 5 mo. In Table I , the pathologic changes occurring in the kidneys of those mice are described. This was associated with a rise in BUN from 10 mg/dl at 1 mo to 40-60 mg/dl at 6 mo of age (Table II) . Changes in PCA expressed by viable splenic macrophages from aging BXSB mice were striking. 1-mo-old mice had values of 37±8 mU/106 splenic macrophages, but even by the 3rd mo of age there was a significant rise to 800±200 mU/ 106 splenic macrophages, with a further elevation at 4 mo to reach a maximum of 29,000±15,000/106 splenic macrophges, which was maintained through 6 mo of age (Table II) . In contrast, no rise in PCA was observed before 8 mo with either BALB/c or C57BV/ 6J mice (data not shown). There was no associated rise of PA over this same time; however, there was a minimal rise in BG that was not evident until late in the course of the animals' disease, and was not consistent as shown by the large standard deviation (Table II) . In separate experiments, in 1-mo-old mice, PCA in splenic mononuclear cells was 5±1/106 cells, in lymphocytes 3±1/106 cells, and in macrophages 50± 10 mU/106 cells. In 4-mo-old animals, the value for splenic mononuclear cells was 2,800±200, in lymphocytes 150±50, and in macrophages 31,000±1,250 mU/106 cells, which shows that the macrophage was the cellular source ofthe PCA-augmented response. Expression of PCA by viable cells was compared with total content PCA assayed in disrupted cells. In 1-mo-old mice, the value obtained from viable splenic cells was 45±10, whereas total content was 35±5 mU/106 splenic macrophages. At 5 mo, viable splenic macrophage PCA was 27,000±3,000 mU/106 splenic macrophages, and total content was 25,500±1,500 mU/106 macrophages, suggesting that the majority of the PCA was localized to the cell surface.
Congenitally factor-deficient human plasmas were used to characterize the PCA, and values were similar when plasma deficient in Factor VII, VIII, X, or V (Helena Laboratories) was used in the assay. However, when Factor II-deficient plasma was used, the clotting time was markedly prolonged. This was corrected by the addition of Factor II, which was devoid ofcontaminants as determined by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (kindly provided by Dr. D. Fair, Scripps Clinic and Research Foundation, La Jolla, CA). In addition, Mo/Ma homogenates, positive for PCA, were able to induce clotting of a system containing only fibrinogen, prothrombin, and calcium. This data demonstrates that the PCA was dependent upon only Factor II, calcium, and fibrinogen for its full activity (Table III) .
Lymphocyte requirement for PCA induction Spleens from 1-and 5-mo-old mice were removed and cells harvested. Lymphocytes were separated from macrophages by cytoadherence, and macrophages were incubated alone or in combination with lymphocytes (at a ratio of 8.5:1 lymphocytes/ macrophage) for 12 h in complete medium in a 5% CO2 atmosphere at 37°C. The cells were harvested, washed three times in RPMI 1640, after which PCA was determined. When splenic lymphocytes and macrophages from 1-mo-old mice were mixed and incubated for 12 h, no augmentation in PCA was found above macrophages from 1-mo-old mice alone (basal activity). In contrast, splenic macrophages alone from 5-mo-old mice or macrophages from 5-mo-old mice mixed with lymphocytes from 1-mo-old mice expressed PCA 1,000-fold higher than levels from 1-mo-old mouse splenic macrophages (Table IV) . Thus, lymphocytes from young animals were not capable ofinhibiting the increased PCA found in macrophages from 5-mo-old mice. When lymphocytes from 5-mo-old mice were mixed with macrophages from one-mo-old mice and incubated for 12-18 h, a marked rise in PCA was observed. The level of activity was similar to that found in macrophages that were isolated from 5-moold BXSB mice. Thus, lymphocytes from 5-mo-old BXSB mice were able to induce PCA expression in macrophages from young mice (Table IV) .
Ability ofplasma to induce macrophage PCA
In an effort to determine whether a factor(s) present in mouse plasma could stimulate PCA induction, plasma from 1-and 5-mo-old mice was studied for its ability to activate peritoneal macrophages from 1-mo-old mice either alone or in the presence of lymphocytes. These data are presented in Table V . Peritoneal macrophages (>98% esterase positive) from young mice, when stimulated (while free of lymphocytes) with plasma from 1-and 5-mo-old mice, failed to produce an augmented PCA response. A marked dose-dependent rise in PCA was seen in peritoneal macrophages mixed with lymphocytes (both from 1-mo-old mice) at a ratio of 8.5:1 when mixed with plasma isolated from 5-mo-old mice, but not when mixed with plasma from 1-mo-old mice. To exclude the presence of an inhibitor of PCA induction in plasma from 1-mo-old mice, plasma from young and old mice was mixed and added to cell preparations. No diminution in PCA was seen as compared with the effect of old plasma alone, suggesting there was not an inhibitor in plasma from young mice (Table V) .
To determine the lymphocyte requirement for PCA induction in response to stimulation with plasma from 5-mo-old mice, lymphocytes from the spleens of young mice were added in increasing numbers to 1 X 106 PEC, and then 50 ul of plasma from 5-mo-old BXSB mice was added. A maximum PCA response was obtained at a lymphocyte macrophage ratio of 1:1, and there was no further increase in PCA as the lymphocyte/ macrophage ratio was increased to 8:1 (Fig. 1) .
Nature oflymphocyte stimulation
To determine whether lymphocyte stimulation occurred through the production of a soluble factor (lymphokine) or by direct cellular contact, 1 X 106splenic mononuclear cells, splenic macrophages, and splenic lymphocytes, from 1-mo-old mice were stimulated with plasma from 5-mo-old mice for 18 h. Supernatants were then collected and added to 1 X 106 macrophages from 1-mo-old mice that were then incubated for an additional 18 h. The results of these studies indicated that lymphocyte supernatants from splenic mononuclear cells and lymphocytes, but not macrophages alone, were able to induce macrophage PCA in a dose-dependent fashion (Table VI) . No such lymphokine was detected in supernatants from lymphocytes that had been incubated with plasma from 1-mo-old mice. In addition, supernatants obtained from lymphocytes from 5-mo-old mice, when placed in culture alone for 18 h, were able to induce an augmented PCA response in young peritoneal/splenic macrophages (data not shown). This PCA-inducing factor, isolated from supernatants derived from incubating plasma from 5-moold mice with lymphocytes from 1-mo-old mice, as well as that derived from lymphocytes from 5-mo-old mice incubated alone, was not IL-1, IL-2, or gamma interferon, as determined by assays carried out as outlined in Methods (data not shown).
Discussion
The BXSB is a recombinant inbred mouse strain derived from a cross between a C57BL/6 female and a SB/LE male. Almost 100% of these mice develop a progressive lethal lupuslike disease that affects males much earlier than females (23) . Like other autoimmune mouse strains, these animals develop lymphoid hyperplasia, B cell hyperactivity, autoantibodies, circulating immune complexes (IC), complement consumption, thymic atrophy, and IC GN. The male mice have a 50% mortality at 5 mo and a 90% mortality at 8 mo, with acute exudative and proliferative GN being the major cause of death (24) .
The pathogenesis of murine lupus is not well understood, but the production of autoantibodies is an associated phenomenon in all strains. Shoenfeld and Schwartz have pointed out that two mechanisms are able to initiate the production of autoantibodies: impaired immunoregulation, which causes the development of autoantibodies against a family of autoantigens, and the idiotype cascade, which could contribute to the production of autoantibodies by means of loopholes in the rules against autoimmunization (25) . Mo/Ma play a major role in the immune and inflammatory response to a variety of agents. These responses can occur consequent to the interactions of these cells with T and B lymphocytes and their products, or through direct interaction of the agents with the Mo/Ma (26) . Activation of the coagulation system is an important aspect of the response to infection in host defense, and is a necessary component of the delayed cutaneous hypersensitivity reaction (27) .
Mo/Ma can be stimulated by lipopolysaccharide (LPS), antigens, immune complexes, viruses, and lipoproteins to augment their expression of PCA (28). The cellular pathways through which this response occurs are not entirely clear and may depend on the particular stimulating agent. Recent evidence suggests a direct role for lymphocytes in the expression of PCA that is induced by LPS and IC (29, 30) . However, others have suggested that LPS can induce Mo/Ma PCA directly (30, 31) . Geczy and colleagues have shown that an Lyt 1+ T cell produces a lymphokine that elicits expression of PCA by adherent cells in response to antigen stimulation (32) , and present further evidence to suggest that this lymphokine is not IL-1, IL-2, or gamma interferon (33). Edgington et al. have described three different T lymphocyte-dependant major pathways for induction ofPCA; the first or rapid pathway appears operative in LPS and IC induction of PCA, the second in allogeneic induction, and the third in antigen-specific induction of PCA (26) .
A number of studies have shown the relevance of Mo/Ma and ofthe coagulation system in GN (6) (7) (8) (9) 34 ). Accordingly, we wondered whether this could indicate a role for Mo/Ma PCA in GN. Previous studies showed that a profound increase in the expression of PCA, which was found to be a direct prothrombinase, correlated with endocapillary proliferation in patients with lupus nephritis and suggested that PCA might be a mediator of tissue injury in this disease (10) . The importance of these observations has been strengthened by the more recent observations of Wiggins et al. using isolated glomeruli, which show an increase in Mo/Ma PCA that is associated with the development of disease and injury in nephrotoxic nephritis in the rabbit (1 1).
The studies presented here demonstrate that the expression of PCA in splenic and peritoneal Mo/Ma correlates with the development of GN in the BXSB mouse and elucidate a mechanism for the induction ofthis monokine. A 1,000-fold increase in PCA was associated with the development of disease, and as we have reported in humans with lupus nephritis (10), this procoagulant was a prothrombinase. This increase in expression of PCA does not appear to reflect a global activation of the Mo/ Ma, as evidenced by the failure of PA and BG to increase in a similar manner. The observation that most of the PCA was localized to the cell surface suggests either that the nature of the stimulant is different from others described, or, that prolonged in vivo stimulation, as opposed to short-term in vitro exposure, minimizes intracellular storage and encourages transport of PCA to the cell surface.
The induction of PCA is lymphocyte dependent, as is evidenced by the observation that lymphocytes from older mice are able to induce increases in PCA in macrophages from young mice similar to levels comparable with the spontaneous PCA seen in cells from animals with severe disease. The lymphocyte effect on the Mo/Ma occurred via soluble mediator(s), and this lymphokine was not IL-1, IL-2, or gamma interferon, molecules that are known to be relevant in other systems. A molecule(s) in the plasma of older mice seems to be responsible for inducing the lymphokine. These data agree with those of Geczy (33) and Edgington (26) who have suggested that a lymphokine specific to the PCA system is relevant in antigen-induced and allogeneicinduced PCA (macrophage procoagulant-inducing factor (MPIF] duction of PCA is related to the interaction oflymphocytes with factor(s) in the plasma, since plasma from older but not younger mice was able to initiate the sequence of events described above in vitro. Of note, all 5-mo-old mouse plasmas were not equipotent in increasing PCA expression although all were definitely positive. This suggests that the quantity of the circulating stimulating factor(s) varies from mouse to mouse and could account for variable disease activity. Thus, data in Fig. 1 and Table V differ in some quantitative aspects. The relevant molecule(s) in the plasma is not known, but a potential candidate would be IC, since these are known to be present in the plasma from the BXSB mouse as well as other autoimmune mice, and since it is known that IC are able to increase Mo/Ma PCA in vitro, (12, 35) .
The studies of Geczy et al. demonstrate antigen-specific induction of PCA in experimental allergic encephalitis (36) . They have shown that mononuclear cells derived from animals immunized with antigens expressed no spontaneous PCA; however, when these cells were rechallenged in vitro by the same antigen, a large increment in PCA was observed. The expression of PCA was seen only in those animals that developed disease. These observations are further evidence in favor of a role for PCA in the mediation of injury in autoimmune disease.
The results of our studies in the BXSB model underline the importance of PCA expression in the development of certain lesions found in spontaneous autoimmune disease in mice. The link between PCA induction and the immunoregulatory abnormalities felt to be relevant in murine lupus is uncertain. We were unable to demonstrate a soluble or lymphocyte-associated suppressor factor capable of blocking PCA induction in young mice. Therefore, any disturbance in immunoregulation must result in the production of a stimulating plasma factor(s). In view of our current understanding of the pathogenesis of GN, and the data presented in this paper, one could postulate that impaired immunoregulation results in the development of IC in the plasma with age in BXSB mice. These IC might then trigger the induction ofa PCA-inducing lymphokine with a major increase in the expression of Mo/Ma PCA. This appears to be intimately associated with the development ofGN, although the exact mechanisms remain to be elucidated.
PCA could be relevant simply as a direct activator of the coagulation system, with resultant regional microcirculatory disturbances in conjunction with fibrin deposition. However,
